GLOBAL CAPITAL PARTNERS INC
SC 13D/A, 2000-12-11
INVESTORS, NEC
Previous: LIBERTY VARIABLE INVESTMENT TRUST, PRE 14C, 2000-12-11
Next: GLOBAL CAPITAL PARTNERS INC, SC 13D/A, EX-99.8, 2000-12-11



<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                               ------------------

                                  SCHEDULE 13D
                                 (RULE 13d-101)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
             TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT
                                TO RULE 13d-2(a)
                               (AMENDMENT NO. 1)(1)

                          GLOBAL CAPITAL PARTNERS, INC.
                                (Name of Issuer)

                     COMMON STOCK, $.05 PAR VALUE PER SHARE
                         (Title of Class of Securities)

                                   276052 10 7
                                 (CUSIP Number)

                              MARTIN A. SUMICHRAST
                          GLOBAL CAPITAL PARTNERS, INC.
                         6000 FAIRVIEW ROAD, SUITE 1410
                         CHARLOTTE, NORTH CAROLINA 28210

                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)


                                DECEMBER 8, 2000
             (Date of Event which Requires Filing of this Statement)

         If the filing person has  previously  filed a statement on Schedule 13G
to report the  acquisition  that is the  subject of this  Schedule  13D,  and is
filing this schedule because of Rule 13d-1(e),  13d-1(f) or 13d-1(g),  check the
following box [ ].

         Note.  Schedules  filed in paper format shall include a signed original
         and five copies of the schedule, including all exhibits. See Rule 13d-7
         for other parties to whom copies are to be sent.

                         (Continued on following pages)

                              (Page 1 of 10 Pages)

--------------------

(1) The  remainder  of this  cover  page  shall be  filled  out for a  reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

         The information  required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  See the
Notes).


<PAGE>




CUSIP No. 276052 10 7                       13D               Page 2 of 10 Pages


1             NAME OF REPORTING PERSONS
              I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
              Belle Holdings, Inc.

2             CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP        (a) |_|
                                                                      (b) |_|
3             SEC USE ONLY

4             SOURCE OF FUNDS
              WC

5             CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS       |_|
              IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

6             CITIZENSHIP OR PLACE OF ORGANIZATION
              State of Nevada

   NUMBER OF SHARES     7           SOLE VOTING POWER
BENEFICIALLY OWNED BY               740,000 shares of Common Stock
EACH REPORTING PERSON
         WITH           8           SHARED VOTING POWER

                        9           SOLE DISPOSITIVE POWER
                                    740,000 shares of Common Stock

                        10          SHARED DISPOSITIVE POWER

11            AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
              740,000 shares of Common Stock

12            CHECK BOX IF THE AGGREGATE AMOUNT IN ROW              |_|
              (11) EXCLUDES CERTAIN SHARES

13            PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
              7.1% shares of Common Stock,  based on 10,460,839 shares of Common
              Stock issued and  outstanding  at November  10,  2000.  See Item 5
              herein.

14            TYPE OF REPORTING PERSON
              CO





                                       2

<PAGE>


CUSIP No. 276052 10 7                       13D            Page 3 of 10 Pages


1             NAME OF REPORTING PERSONS
              I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
              Martin A. Sumichrast

2             CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP      (a) |_|
                                                                    (b) |_|
3             SEC USE ONLY

4             SOURCE OF FUNDS
              PF

5             CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS      |_|
              IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

6             CITIZENSHIP OR PLACE OF ORGANIZATION
              United States of America

   NUMBER OF SHARES     7      SOLE VOTING POWER
BENEFICIALLY OWNED BY          1,165,000 shares of Common Stock (includes 75,000
EACH REPORTING PERSON          shares subject to currently exercisable  options,
         WITH                  150,000 shares subject to currently exercisable
                               warrants and 740,000 shares of which Belle
                               Holdings is the direct beneficial owner)

                        8      SHARED VOTING POWER
                               1,960,000 shares of Common Stock (pursuant to the
                               Voting Agreement and Irrevocable Proxy dated
                               December 8, 2000 and incorporated by reference
                               as Exhibit 99.8 to this Schedule 13D)

                        9      SOLE DISPOSITIVE POWER
                               1,165,000 shares of Common Stock (includes 75,000
                               shares subject to currently currently exercisable
                               options, 150,000 shares subject  to  currently
                               exercisable  warrants and 740,000 shares of which
                               Belle Holdings is the direct beneficial owner)

                        10     SHARED DISPOSITIVE POWER


11            AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
              3,125,000 shares of Common Stock (Mr. Sumichrast disclaims
              beneficial ownership of the 1,960,000 shares of Common Stock
              currently subject to the Voting Agreement and Irrevocable Proxy)

12            CHECK BOX IF THE AGGREGATE AMOUNT IN ROW         |_|
              (11) EXCLUDES CERTAIN SHARES

13            PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
              29.2% shares of Common Stock, based on 10,460,839 shares of Common
              Stock issued and outstanding at November 10, 2000.

14            TYPE OF REPORTING PERSON
              IN


                                       3

<PAGE>



         This Amendment No. 1 to Schedule  13D  amends the Schedule 13D dated as
of June 30, 2000. This Amendment No. 1 amends and restates the statement to read
in its entirety as follows:

ITEM 1.   SECURITY AND ISSUER.

         This statement  relates to shares of common stock,  $.05 par value (the
"Common Stock"), of Global Capital Partners, Inc., a Delaware corporation having
its principal  executive  offices at 6000 Fairview Road, Suite 1410,  Charlotte,
North Carolina 28210 (the "Company").

         The   Company   changed   its   name   from  Eastbrokers  International
Incorporated  ("Eastbrokers") to Global Capital Partners, Inc. in February 2000.
Accordingly,  any  reference  in this  Schedule  13D to  Eastbrokers  means  the
Company.

ITEM 2.   IDENTITY AND BACKGROUND.

         (a)      The  names  of  the  persons  filing  this statement are Belle
                  Holdings,  Inc., a Nevada corporation ("Belle  Holdings"), and
                  Martin  A.  Sumichrast  ("Mr.  Sumichrast," together with Bell
                  Holdings, the "Filers").

         (b)      The  address  of  the Filers is 6000 Fairview Road, Suite 1410
                  Charlotte, North Carolina  28210.

         (c)      Mr.  Sumichrast  is the sole director, officer and shareholder
                  of Belle Holdings.

         (d)      During  the last five  years,  neither  of the Filers has been
                  convicted  in  a  criminal   proceeding   (excluding   traffic
                  violations or similar misdeameanors).

         (e)      During the last five years,  neither of the Filers was a party
                  to a civil proceeding of a judicial or administrative  body of
                  competent  jurisdiction and as a result of such proceeding was
                  or is subject to a judgment,  decree or final order  enjoining
                  future  violations of, or prohibiting or mandating  activities
                  subject to,  federal or state  securities  laws or finding any
                  violation with respect to such laws.

         (f)      Mr. Sumicharst is a citizen of the United States of America.

ITEM 3.   SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

         Belle  Holdings  used   $4,000,000   received  from  the  sale  of  its
Convertible  Notes Due  December  31, 2004 (the  "Convertible  Notes") to Corona
Corp.  ("Corona")  to purchase  2,000,000  shares of 10%  Convertible  Preferred
Stock,  Series A (the "Preferred Stock") of the Company and 700,000 common stock
purchase warrants (the "Warrants").

ITEM 4.   PURPOSE OF TRANSACTION.

         The 740,000 shares of Common Stock beneficially owned by Belle Holdings
and  425,000  shares  of  Common  Stock  beneficially  owned  by Mr.  Sumichrast
referenced herein were acquired for investment purposes.

         On  December  8, 2000,  Corona and the  Company  entered  into a Voting
Agreement  and  Irrevocable  Proxy (the  "Voting  Agreement")  pursuant to which
Corona agreed,  for a five-year period, to vote all shares of Common Stock owned
by it as directed by the Company's board of directors. In order to secure


                                       4
<PAGE>

Corona's obligations,  the Voting Agreement also provides for the granting of an
irrevocable proxy by Corona to Mr. Sumichrast and any subsequent chief executive
officer of the  Company,  for the  purpose of voting all shares of Common  Stock
owned by Corona.

         While the  Filers  (and  their  affiliates)  have no  present  plans or
proposals  which relate to or would result in the  acquisition or disposition by
any person of securities of the Company,  the  investments in the Company by the
Filers (and their affiliates) will be periodically  reviewed and at any time the
amount of such  investments may be increased,  through open market  purchases or
otherwise,  or decreased.  Except as otherwise set forth in this statement,  the
Filers  (and  their  affiliates)  do not at the  present  time have any plans or
proposals which relate to or would result in:

         (a)      The  acquisition by any person of additional securities of the
                  Company,  or the  disposition  of securities of the Company;

         (b)      An  extraordinary  corporate  transaction,  such  as a merger,
                  reorganization or liquidation, involving the Company or any of
                  its subsidiaries;

         (c)      A  sale  or  transfer  of  a  material amount of assets of the
                  Company or any of its subsidiaries;

         (d)      Any change in the present  Board of Directors or management of
                  the  Company,  including  any plans or proposals to change the
                  number or term of directors or to fill any existing  vacancies
                  on the Board;

         (e)      Any  material change in the present capitalization or dividend
                  policy of the Company;

         (f)      Any  other  material  change  in  the  Company's  business  or
                  corporate structure;

         (g)      Changes in the Company's Certificate of Incorporation, by-laws
                  or instruments corresponding thereto or  other  actions  which
                  may  impede  the  acquisition of control of the Company by any
                  person;

         (h)      Causing a class of  securities  of the  Company to be delisted
                  from  a  national  securities  exchange  or  to  cease  to  be
                  authorized to be quoted in an inter-dealer quotation system of
                  a registered national securities association;

         (i)      A class of equity  securities of the Company becoming eligible
                  for  termination  of registration pursuant to Section 12(g)(4)
                  of the Securities Exchange Act of 1934; or

         (j)      Any action similar to any of those enumerated above.

ITEM 5.   INTEREST IN SECURITIES OF THE ISSUER.

Belle Holdings

         As of the date hereof, Belle Holdings is the direct beneficial owner of
740,000  shares of Common  Stock of the  Company,  over which it has sole voting
power and sole power to dispose.  This number  represents 7.1% of the issued and
outstanding  shares of Common Stock of the Company,  based on 10,460,839  shares
issued and outstanding at November 10, 2000.

                                       5
<PAGE>

Mr. Sumichrast

         As of  the  date  hereof,  Mr.  Sumichrast  may  be  deemed  to be  the
beneficial owner of 3,125,000 shares of Common Stock of the Company. This number
represents  29.2% of the issued and  outstanding  shares of Common  Stock of the
Company, based on 10,460,839 shares issued and outstanding at November 10, 2000.
Of the  3,125,000  shares,  Mr.  Sumichrast  is the direct  beneficial  owner of
425,000 shares,  including 75,000 shares issuable upon the exercise of currently
exercisable  options at an exercise  price of $4.50 per share and 150,000 shares
issuable  upon the  exercise of  currently  exercisable  warrants at an exercise
price of $7.00 per share.

         As the sole director,  officer and shareholder of Belle  Holdings,  Mr.
Sumichrast is an indirect beneficial owner of the 740,000 shares of Common Stock
of which Belle Holdings is the direct  beneficial  owner and he may be deemed to
have the sole power to direct the vote and to dispose of such shares.

         As a result of the Voting Agreement,  Mr. Sumichrast may also be deemed
to be the  beneficial  owner of the 1,960,000  shares of Common Stock  currently
subject to the Voting  Agreement and to have shared voting power with respect to
such shares.  Mr.  Sumichrast  disclaims  beneficial  ownership of the 1,960,000
shares of Common Stock currently subject to the Voting Agreement.

         During the last 60 days, Mr. Sumichrast has not acquired or disposed of
any shares of Common Stock, except for 40,000 shares of Common Stock sold in the
open market on October 2, 2000 at a purchase price of $6.25 per share.

ITEM 6.    CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
           TO SECURITIES OF THE ISSUER.

         On November  9, 1999,  Belle  Holdings  entered  into a Stock  Purchase
Agreement with the Company (the "Stock  Purchase  Agreement")  pursuant to which
Belle Holdings purchased 1,000,000 shares of Preferred Stock for $2.00 per share
and Warrants to purchase an  aggregate  of 700,000  shares of Common Stock at an
exercise  price of $2.85 per share and also received an option to purchase up to
an  additional  1,000,000  shares of  Preferred  Stock at $2.00 per  share.  The
Preferred Stock was convertible into shares of Common Stock on a 1:1 basis.

         On November 10, 1999.  Belle  Holdings  entered into an Investment  and
Stock Purchase  Agreement  with Corona  pursuant to which Belle Holdings sold to
Corona $1 million of its Convertible  Notes  convertible  from time to time into
shares of Preferred Stock owned by Belle Holdings on a 0.35:1 basis and Warrants
to purchase an aggregate of 490,000 shares of Common Stock.

         On January 10, 2000, Belle Holdings partially  exercised its option and
purchased  an  additional  100,000  shares of Preferred  Stock.  Simultaneously,
Corona partially exercised its option and purchased additional Convertible Notes
in the principal amount of $200,000.

         As of the date of the Stock Purchase Agreement, each share of Preferred
Stock was  entitled to one vote on all matters  submitted  to  stockholders  for
approval. The Company agreed to seek stockholder approval to increase the voting
power of the  Preferred  Stock  from one vote per share to four votes per share,
which would  result in the increase of voting power held by holders of Preferred
Stock from  approximately 14% to approximately  39%. These terms were negotiated
by Corona,  having  contemplated  that Mr. Sumichrast would participate in Belle
Holdings, in order to more fully align the interests of the Company's management
with those of its stockholders.

                                       6
<PAGE>

         Subsequent to  stockholder  approval of the increase in voting power of
the  Preferred  Stock,  the Nasdaq Stock Market  informed the Company that their
listing  requirements  prohibit  designating any class of security with a higher
voting right than any other  class.  Additionally,  Nasdaq  informed the Company
that pursuant to other listing  requirements,  the initial $2.00 per share price
of the  Preferred  Stock had to be increased  to $2.0625 per share,  the closing
price of the Common Stock on November 8, 2000. Accordingly, on January 31, 2000,
Belle  Holdings  agreed to convert all of its shares of  Preferred  Stock and to
exercise its  Warrants.  In  consideration,  the Company sold to Belle  Holdings
Class D Warrants to purchase an aggregate of 1,500,000 shares of Common Stock at
an exercise price of $5.50 per share in exchange for a $375,000  promissory note
due July 1, 2001 and bearing  interest at 8% per annum. The Class D Warrants are
exercisable  as of July 1, 2001 and expire  December 31, 2005. On the same date,
Belle  Holdings sold to Corona and a third party Class D Warrants to purchase up
to  900,000  and  200,000  shares  of Common  Stock,  respectively.  In  further
consideration of these changes,  on March 31, 2000,  Belle Holdings  transferred
70,000 shares of Common Stock to Corona.

         On March 31, 2000, Corona exercised the remaining portion of its option
and  purchased  additional  Convertible  Notes in the  principal  amount of $1.8
million. On this date, Corona also converted all of its Convertible Notes in the
aggregate  principal  amount of $4.0 million into 1,400,000  shares of Preferred
Stock,  converted the 1,400,000  shares of Preferred Stock into 1,400,000 shares
of Common Stock and exercised  its Warrants for 490,000  shares of Common Stock.
Simultaneously,  Belle  exercised  the  remaining  portion  of  its  option  and
purchased from the Company 900,000 shares of Preferred Stock.

         On the same date, Belle Holdings  converted 600,000 shares of Preferred
Stock into 600,000 shares of Common Stock,  transferred the remaining  1,400,000
shares of Preferred Stock to Corona upon conversion of the Convertible Notes and
exercised the remaining Warrants for 210,000 shares of Common Stock.

         See Item 4 hereof for a description of the Voting Agreement.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

99.1.    Joint  Filing  Agreement,  dated  June  30,  2000,  by  and among Belle
         Holdings and Mr. Sumichrast (previously filed).

99.2.    Stock Purchase Agreement,  by and among Eastbrokers and Belle Holdings,
         dated as of November 9, 1999, and amendment thereto (previously filed).

99.3.    Warrant Agreement, between Eastbrokers and Belle Holdings, dated  as of
         November 9, 1999 (previously filed).

99.4.    Common Stock Purchase Warrant Certificate No. 1, dated November 9, 1999
         (previously filed).

99.5.    Common Stock Purchase Warrant Certificate No. 2, dated November 9, 1999
         (previously filed).

99.6.    Investment and Stock Purchase  Agreement dated as of November 10, 1999,
         by and between  Belle  Holdings  and  Corona,  and  amendments  thereto
         (previously filed).

99.7.    Convertible Note Due December 31, 2004, by  and  between Belle Holdings
         and Corona, dated November 10, 1999 (previously filed).

                                       7
<PAGE>


99.8     Voting  Agreement  and  Irrevocable  Proxy,  dated as of  December 8,
         2000,  by and between  Corona and the Company  (filed  herewith).





































                                       8
<PAGE>



                                   SIGNATURES

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Date:  December 11, 2000             BELLE HOLDINGS, INC.



                                     By:      /s/ Martin A. Sumichrast
                                     -----------------------------------------
                                                 Martin A. Sumichrast
                                        Sole Director, Officer and Stockholder





                                              /s/ Martin A. Sumichrast
                                     -----------------------------------------
                                                 Martin A. Sumichrast


















                                       9
<PAGE>



                                INDEX TO EXHIBITS

     EXHIBIT NO.                                      DESCRIPTION

       99.1         Joint  Filing  Agreement,  dated June 30, 2000, by and among
                    Belle Holdings and Mr. Sumichrast (previously filed).

       99.2         Stock Purchase Agreement, by and among Eastbrokers and Belle
                    Holdings,  dated  as of  November  9,  1999,  and  amendment
                    thereto (previously filed).

       99.3         Warrant  Agreement,  between Eastbrokers and Belle Holdings,
                    dated as of November 9, 1999 (previously filed).

       99.4         Common  Stock  Purchase  Warrant  Certificate  No.  1, dated
                    November 9, 1999 (previously filed).

       99.5         Common  Stock  Purchase  Warrant  Certificate  No.  2, dated
                    November 9, 1999 (previously filed).

       99.6         Investment and Stock Purchase Agreement dated as of November
                    10, 1999,  by and between  Belle  Holdings  and Corona,  and
                    amendments thereto (previously filed).

       99.7         Convertible Note Due December 31, 2004, by and between Belle
                    Holdings and Corona, dated November 10, 1999
                    (previously filed).

       99.8         Voting  Agreement and Irrevocable  Proxy,  dated as of
                    December 8, 2000, by and between Corona and the Company
                    (filed herewith).











                                       10



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission